Madden Securities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,945
Closed -$323K 118
2025
Q1
$323K Sell
1,945
-250
-11% -$39.1K 0.13% 93
2024
Q4
$318K Sell
2,195
-4,415
-67% -$684K 0.13% 97
2024
Q3
$1.07M Sell
6,610
-100
-1% -$15.9K 0.46% 53
2024
Q2
$981K Buy
+6,710
New +$998K 0.43% 54
2024
Q1
Sell
-1,688
Closed -$265K 101
2023
Q4
$265K Buy
+1,688
New +$259K 0.14% 80
2023
Q3
Sell
-2,240
Closed -$371K 88
2023
Q2
$371K Sell
2,240
-225
-9% -$36.3K 0.19% 70
2023
Q1
$382K Sell
2,465
-25
-1% -$4.04K 0.2% 69
2022
Q4
$440K Sell
2,490
-300
-11% -$51.8K 0.23% 71
2022
Q3
$456K Hold
2,790
0.28% 68
2022
Q2
$495K Sell
2,790
-54
-2% -$9.62K 0.27% 67
2022
Q1
$504K Buy
2,844
+565
+25% +$96.1K 0.23% 71
2021
Q4
$390K Sell
2,279
-269
-11% -$44K 0.18% 80
2021
Q3
$412K Sell
2,548
-265
-9% -$45.2K 0.22% 79
2021
Q2
$463K Buy
2,813
+1
+0% +$166 0.24% 95
2021
Q1
$462K Sell
2,812
-24
-0.8% -$3.88K 0.27% 92
2020
Q4
$446K Sell
2,836
-260
-8% -$38.4K 0.29% 92
2020
Q3
$461K Buy
3,096
+266
+9% +$39.4K 0.34% 82
2020
Q2
$398K Buy
+2,830
New +$412K 0.35% 69
2019
Q4
$536K Buy
+3,678
New +$499K 0.54% 54

Other funds holding JNJ

Madden Securities's JNJ Position: Q2 2025 in Review

Madden Securities sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 1,945 shares — an estimated $323K sold.

Madden Securities first reported a position in JNJ in Q4 2019 and held it in 19 quarters. The position peaked at $1.07M in Q3 2024. 4,082 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • Madden Securities reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
  • Madden Securities sold 1,945 Johnson & Johnson shares in Q2 2025, an estimated $323K.
  • Madden Securities first reported a position in Johnson & Johnson in Q4 2019 and held it in 19 quarters.
  • Madden Securities's Johnson & Johnson position peaked at $1.07M in Q3 2024.
  • 4,082 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Madden Securities's 13F filing for Q2 2025, filed 23 Jul 2025.